Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Mexiletine HCl 150 mg Oral Capsules (Gluten Free)

FDA-approved generic
Dose form
Capsules
Active ingredients
Mexiletine Hydrochloride
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Save 15% on every refill when you enroll in Automatic Refills
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Mexiletine Hydrochloride
Capsules
6427079ea643243913518e45
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded capsule containing mexiletine hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing mexiletine are listed in capsule form.

Storage category and dating

This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Mexiletine is a class IB antiarrhythmic taken by mouth; compounded preparations require a prescription and are not FDA-approved.

About this ingredient

Mexiletine hydrochloride is an antiarrhythmic and local anesthetic agent that is structurally similar to lidocaine but active by mouth. Like lidocaine, it blocks the inward sodium current in heart cells, slowing the rise of the cardiac action potential. The manufactured products are generic mexiletine hydrochloride capsules, indicated for documented ventricular arrhythmias, such as sustained ventricular tachycardia, that the physician judges to be life-threatening. Drugs@FDA lists the Mexitil brand application as discontinued and several generic capsule applications as prescription products. A prescriber may order mexiletine compounded when a patient needs an oral liquid; the International Journal of Pharmaceutical Compounding has published a mexiletine hydrochloride oral suspension formulation. Topical gels containing mexiletine are not an FDA-approved use. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

The mexiletine label carries a boxed warning: in the Cardiac Arrhythmia Suppression Trial (CAST), heart attack survivors with non-life-threatening ventricular arrhythmias who took encainide or flecainide had more deaths or nonfatal cardiac arrests than those on placebo. Because mexiletine can also worsen arrhythmias, the label reserves it for life-threatening ventricular arrhythmias. Do not take it if you have cardiogenic shock or second- or third-degree heart block without a pacemaker. The label also warns of liver injury, DRESS (a serious rash and organ reaction), blood count changes and seizures, and advises caution with low blood pressure and severe heart failure. Fluvoxamine, propafenone, cimetidine, phenytoin, rifampin and phenobarbital can change mexiletine levels, and mexiletine can raise theophylline levels. In pregnancy, the label advises use only if benefit justifies risk. It passes into breast milk; the label suggests another feeding method, while LactMed expects no harm to breastfed infants from the low milk levels. For stomach upset, dizziness or tremor, talk to your prescriber or pharmacist.

Mexiletine is a class IB antiarrhythmic that inhibits the inward sodium current, reducing the rate of rise of phase 0. Oral absorption is about 90% with low first-pass metabolism; peak levels occur in two to three hours; plasma elimination half-life is about 10 to 12 hours in normal subjects; protein binding is 50 to 60% and volume of distribution 5 to 7 L/kg. About 90% is metabolized in the liver to inactive metabolites, mainly by CYP2D6 and also by CYP1A2, with poor and extensive CYP2D6 metabolizer phenotypes. Fluvoxamine decreased mexiletine clearance by 38%, and propafenone reduced its metabolic clearance by about 70% in extensive metabolizers; enzyme inducers lower levels. Avoid drugs or diets that markedly change urinary pH. Labeled indication (mexiletine hydrochloride capsules, Macleods): documented life-threatening ventricular arrhythmias; use with asymptomatic ventricular premature contractions should be avoided. StatPearls describes a role in peripheral neuropathy and chronic pain, limited by adverse effects, and use in myotonia; these are not FDA-approved indications. Dosing and titration per prescriber; the label notes gastrointestinal and nervous system effects may lessen with food or antacid. Monitor ECG, liver tests, blood counts and signs of DRESS, and plasma levels when enzyme inducers are used.

Sources

Using and storing

How it is used

Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.

Storing it

Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Mexiletine HCl 150 mg Oral Capsules (Gluten Free)
Capsules
90 capsules
controlled

Take 1 capsule by mouth

Every 8 hours